Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Rectal Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02381561
What this trial is testing

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

Who this might be right for
Advanced Bile Duct CarcinomaStage II Esophageal Cancer AJCC v7Stage II Pancreatic Cancer AJCC v6 and v7+38 more
National Cancer Institute (NCI) 19
Not applicableStudy completedNCT07502469
What this trial is testing

Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic Lesions After a Positive Immunological Test in the Context of Organized Colorectal Cancer (BENEFIT)

Who this might be right for
Colorectal CancerColo-rectal Cancer
Elsan 341
Not applicableUnknownNCT03426397
What this trial is testing

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

Who this might be right for
Rectal Neoplasms
The Netherlands Cancer Institute 220
Not applicableStudy completedNCT01591590
What this trial is testing

Correlating the Tumoral Metabolic Progression Index to Patient's Outcome in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jules Bordet Institute 53
Not applicableStudy completedNCT06048146
What this trial is testing

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

Who this might be right for
Lymph Node MetastasisCancer of Rectum and AnusOxaliplatin+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 180
Not applicableEnded earlyNCT02885142
What this trial is testing

Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery?

Who this might be right for
Anal Cancer
Assistance Publique Hopitaux De Marseille 368
Large-scale testing (Phase 3)Active Not RecruitingNCT04928807
What this trial is testing

Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

Who this might be right for
Rectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 231
Testing effectiveness (Phase 2)Study completedNCT03085992
What this trial is testing

Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Azienda Ospedaliero, Universitaria Pisana 49
Not applicableActive Not RecruitingNCT02438839
What this trial is testing

Curative Chemoradiation of Low Rectal Cancer

Who this might be right for
Rectal Cancer
Vejle Hospital 108
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Early research (Phase 1)UnknownNCT04906044
What this trial is testing

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more
The First Hospital of Jilin University 46
Not applicableStudy completedNCT03057288
What this trial is testing

Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer

Who this might be right for
Esophageal NeoplasmRectal Neoplasms
Société Française d'Endoscopie Digestive 40
Early research (Phase 1)Study completedNCT00543842
What this trial is testing

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT02941562
What this trial is testing

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

Who this might be right for
Rectal Cancer, Radiotherapy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)Ended earlyNCT00766142
What this trial is testing

Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPrimary Peritoneal Cavity Cancer
Institut Bergonié 18
Testing effectiveness (Phase 2)Study completedNCT00083720
What this trial is testing

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Who this might be right for
Colorectal NeoplasmsMetastasesNeoplasm
Eli Lilly and Company 87
Not applicableStudy completedNCT01938027
What this trial is testing

The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision

Who this might be right for
Rectal Cancer
National Cancer Center, Korea 12
Not applicableStudy completedNCT04836741
What this trial is testing

Chinese Surgical Robot Clinical Study on Rectectomy for Rectal Cancer

Who this might be right for
Rectal Cancer
The Third Xiangya Hospital of Central South University 105
Next Page